795113

Repro Lab, Inc. — FEI 3000974212

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 21, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1223021 CFR 1271.50(a)Responsible person to determine, document